Call Options

9 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$0.13 - $76.84 $18,278 - $10.8 Million
140,600 Added 1026.28%
154,300 $11 Million
Q3 2022

Nov 14, 2022

BUY
$0.13 - $76.84 $18,278 - $10.8 Million
140,600 Added 1026.28%
154,300 $11 Million
Q2 2022

Aug 15, 2022

BUY
$72.62 - $79.98 $232,384 - $255,936
3,200 Added 30.48%
13,700 $1.06 Million
Q1 2022

May 16, 2022

SELL
$61.48 - $73.72 $4.68 Million - $5.61 Million
-76,100 Reduced 87.88%
10,500 $767,000
Q4 2021

Feb 14, 2022

BUY
$53.63 - $62.52 $2.58 Million - $3.01 Million
48,100 Added 124.94%
86,600 $5.4 Million
Q3 2021

Nov 15, 2021

BUY
$59.17 - $69.31 $710,040 - $831,720
12,000 Added 45.28%
38,500 $2.28 Million
Q2 2021

Aug 16, 2021

SELL
$61.91 - $67.42 $1.46 Million - $1.59 Million
-23,600 Reduced 47.11%
26,500 $1.77 Million
Q1 2021

May 17, 2021

BUY
$59.34 - $66.74 $1.6 Million - $1.8 Million
26,900 Added 115.95%
50,100 $3.16 Million
Q4 2020

Feb 16, 2021

BUY
$57.74 - $65.43 $1.34 Million - $1.52 Million
23,200 New
23,200 $1.44 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Point72 Hong Kong LTD Portfolio

Follow Point72 Hong Kong LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

News

Stay updated on Point72 Hong Kong LTD with notifications on news.